Proton Intelligence

Canada
Sydney Forks, Nova Scotia, Canada

Company profile

Proton Intelligence company profile

Proton Intelligence provides biomarker monitoring to manage chronic disease and save lives. The first biomarker is potassium, targeting hyperkalemia in chronic kidney disease (CKD) patients who have additional co-morbidities ProtonIntel was founded in 2020 and was headquartered in Vancouver, Canada.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2020-11-17

Headquarters

Country code
CA
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
5
Total equity funding
$7M
Last funding
Seed / $7M / 2024-12-24
Last equity funding
Seed / $7M
Investors
13
Lead investors
3
Articles
17

Founders and investors

Lead investors

MedTech InnovatorPlug and PlaySOSV

Investors

AIN VenturesEXOR N.V.IndieBioPlug and PlaySOSV